FPR2 and atherosclerosis: demonstrated, clarifying the role of SPM receptors such as ALX/FPR2 and their pathway might benefit pharmacologic therapeutic approaches for vascular diseases such as atherosclerosis and aortic aneurysm (Petri et al., 2015, 2018).